Acne

Role of retinoids in acne set to be cemented further with advent of first fourth generation product.

Before 2018 comes to a close, we wanted to say thank you to our readers from everyone here at Dermatology Times. As a thank you, we have compiled a list of the topics and issues you found most compelling throughout the year. Enjoy this slideshow - and see you in 2019!

Oral and topical statins can be an effective addition to treatment for acne vulgaris when combined with standard treatment, suggests the results of a study published online in Current Clinical Pharmacology.

Small study shows that this topical solution could be as effective for treating post acne scarring as microneedling.

The U.S. Food and Drug Administration has approved clearance for a new acne treatment that selectively targets sebaceous glands, according to a news release.

The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.

Pilot study suggests topical gel effective as monotherapy for acne vulgaris of the trunk.

Study shows novel minocycline foam appears to be effective in moderate to severe acne vulgaris and is well-tolerated in phase three trials.

Long lauded for its ability to reduce the appearance of wrinkles, botulinum toxin is now being considered for reducing scarring.

Approximately 40% of acne patients have scars - and scarring can occur in any severity of acne. Watch Dr. Joshua Zeichner discuss his approach to the treatment of acne for teens and young adults.

Intense pulsed light therapy is an effective treatment for severe acne in dark-skinned women, say researchers writing in the Journal of Clinical and Aesthetic Dermatology.

Combining metformin and oral contraceptives to treat polycystic ovarian syndrome has little impact on quality of life measures including acne, a study shows.

The FDA has approved Ortho Dermatologic’s new drug application for Altreno (tretinoin 0.05 percent) lotion for the treatment of acne vulgaris.

Kleresca's new biophotonic technology received CE mark of approval, which will allow it to expand in the U.S., Canada, Australia and throughout Europe.

Can clinicians working for Catholic health care organizations prescribe the birth control pill for acne? A recent article discusses the ethical and legal problems these clinicians face when patients request to be treated with oral contraceptives.

A low glycemic index and glycemic load diet decreases IGF-1 concentrations, a well-established risk factor in the pathogenesis of acne pathogenesis indicating that such diets have the potential to reduce the impact of acne, a study suggests.

Effective therapeutic protocols for acne scarring should consider the multifacted aspects of scarring, such as erythema (redness), signs of bacterial infection, signs of atrophic scars and whether the scars are generalized or individualized.

Dermatologists should consider using the diuretic drug spironolactone to treat acne in women instead of antibiotics, researchers report. 

Study of 144 female students shows that stress may increase acne severity.

The September 2018 issue of Dermatology Times includes a special supplment on treating acne scarring. It highlights some of the latest advances in treating patients who suffer from this condition.

“As dermatologists, we are trained in managing acne. We can provide early and effective treatment that improves the physical and psychological effects. It is up to us to bridge the gap between those suffering from acne and their access to medical treatment." 

Researchers writing in the Journal of Clinical and Aesthetic Dermatology outline 10 treatments for acne scarring, plus possible future treatments.

Treatment may offer an alternative to topical retinoid treatments for acne scarring.

The intensity and duration of the inflammatory reaction in acne causes dermal damage and alteration of the sebaceous gland structure leading to atrophic scar formation, but not all patients are affected equally.

Superficial chemical peels have a relatively low complication rate in patients with darker skin types when performed appropriately, a study finds.